Clinical Trials Logo

Neuropathic Pain clinical trials

View clinical trials related to Neuropathic Pain.

Filter by:

NCT ID: NCT03710967 Active, not recruiting - Neuropathic Pain Clinical Trials

Bilateral TMS vs. Unilateral TMS

biTMSvsuniTMS
Start date: May 1, 2018
Phase: N/A
Study type: Interventional

Rationale: In 2016, Henssen et al. discuss that orofacial pain may be conducted in a bilateral fashion, inducing activation of both thalami [1]. For this reason, bilateral stimulation of the motor cortex is thought to induce a stronger analgesic effect compared to unilateral motor cortex stimulation by transcranial magnetic stimulation. Objective: To investigate the superiority of bilateral transcranial magnetic stimulation (TMS) over unilateral TMS of the motor cortex Study design: Double-blind, randomized controlled trial Study population: Patients that suffer from chronic orofacial pain and have not been treated (yet) with any form of neuromodulation. Intervention (if applicable): One group receives bilateral TMS whereas the other group receives unilateral TMS for one month. After one month, the groups switch treatment protocol. Main study parameters/endpoints: Modification in intensity of pain as measured using the VAS, the influence the relief of pain with regard to quality of life and daily activities using the McGill Pain Questionnaire. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Time investment of patients.

NCT ID: NCT03686774 Not yet recruiting - Neuropathic Pain Clinical Trials

Memantine and Post-mastectomy Neuropathic Pain

CLEMANTINE
Start date: January 1, 2019
Phase: Phase 2
Study type: Interventional

The aim of this study is to evaluate if memantine administered for four weeks starting two weeks before surgery induces a decrease in pain intensity at 3 months post-mastectomy.

NCT ID: NCT03664921 Not yet recruiting - Neuropathic Pain Clinical Trials

Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy

Start date: October 1, 2018
Phase: Phase 2
Study type: Interventional

This study evaluates the analgesic effect of Omnitram for the treatment of painful diabetic neuropathy. Each subject with diabetic neuropathy will be treated for four weeks with Omnitram and for four weeks with placebo. The order of the Omnitram and placebo treatment will be random.

NCT ID: NCT03638869 Completed - Neuropathic Pain Clinical Trials

Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REL-1017 (d-Methadone)

Start date: August 31, 2015
Phase: Phase 1
Study type: Interventional

This study evaluated the safety, tolerance, and pharmacokinetics (PK) of d-methadone in a limited dose range, in multiple administrations in humans.

NCT ID: NCT03637361 Completed - Neuropathic Pain Clinical Trials

Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of REL-1017 (d-Methadone)

Start date: December 4, 2014
Phase: Phase 1
Study type: Interventional

This study evaluated the safety, tolerance, and pharmacokinetics (PK) of d-methadone in a limited dose range, in single administrations in humans.

NCT ID: NCT03592394 Active, not recruiting - Clinical trials for Spinal Cord Injuries

Virtual Reality for Chronic Neuropathic Pain

Start date: July 2016
Phase: Phase 3
Study type: Interventional

The investigators hypothesize that SCI patients using immersive IVR training will show improved reduction of neuropathic pain that will outlast the training sessions and transfers into daily life.

NCT ID: NCT03587220 Recruiting - Neuropathic Pain Clinical Trials

A Mechanistic Evaluation of the Nociceptive Desensitizing Properties of Topical Capsaicin

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

The aim of this project is to study the role of transient receptor potential (TRP-) channel V1 (TRPV1+) fibers in the development of cutaneous inflammation induced by epidermal Ultraviolet-B damage. Moreover, in this project the investigators want to evaluate if the capsaicin-desensitization action can still be induced in a skin area pretreated with topical, local anesthetic lidocaine.

NCT ID: NCT03559985 Recruiting - Neuropathic Pain Clinical Trials

Paracetamol and Neuropathic Pain

PAeoNy
Start date: August 20, 2018
Phase: Phase 2
Study type: Interventional

The aim of this study is to evaluate the analgesic effect of paracetamol in patients suffering from pain with a peripheral neuropathic component in the presence of their usual treatment.

NCT ID: NCT03556137 Not yet recruiting - Neuropathic Pain Clinical Trials

PET/MRI in the Diagnosis of Chronic Pain

Start date: June 2018
Phase: Phase 1
Study type: Interventional

Several studies have implicated involvement of sigma-1 receptors (SR1s) in the generation of chronic pain, while others are investigating anti SR1 drugs for treatment of chronic pain. Using [18F]-FTC-146 and positron emission tomography/magnetic resonance imaging (PET/MRI), the investigators hope to identify the source of pain generation in patients with chronic pain. The purpose of this study is to compare the uptake of [18F]FTC-146 in healthy volunteers to that of individuals suffering from chronic pain.

NCT ID: NCT03544619 Enrolling by invitation - Neuropathic Pain Clinical Trials

Reliability and Cross-cultural Adaptation of the Turkish Version of the Neuropathic Pain Symptom Inventory

Start date: June 10, 2018
Phase:
Study type: Observational [Patient Registry]

In this study, investigators want to perform the reliability and cross-cultural Adaptation of the Turkish Version of the Neuropathic Pain Symptom Inventory